Complement activation and atherosclerosis
- 1 September 1999
- journal article
- Published by Elsevier in Molecular Immunology
- Vol. 36 (13-14) , 949-955
- https://doi.org/10.1016/s0161-5890(99)00117-0
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Immunohistochemical Colocalization of the Terminal Complex of Human Complement and Smooth Muscle Cell α-Actin in Early Atherosclerotic LesionsArteriosclerosis, Thrombosis, and Vascular Biology, 1997
- Complement C5b-9 Increases Plasminogen Binding and Activation on Human Endothelial CellsArteriosclerosis, Thrombosis, and Vascular Biology, 1997
- G1 phase progression: Cycling on cueCell, 1994
- C5a-induced expression of P-selectin in endothelial cells.Journal of Clinical Investigation, 1994
- Pharmacology of smooth muscle cell replication.Hypertension, 1992
- CD59 (homologous restriction factor 20), a plasma membrane protein that protects against complement C5b-9 attack, in human atherosclerotic lesionsAtherosclerosis, 1992
- Growth Factors Proto-Oncogenes and Plasticity of the Cardiac PhenotypeAnnual Review of Physiology, 1991
- Complement receptors and regulatory proteins in human atherosclerotic lesions.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1989
- Generation of complement anaphylatoxins and C5b-9 by crystalline cholesterol oxidation derivatives depends on hydroxyl group number and position☆Molecular Immunology, 1987
- Complement and arteriosclerosisAtherosclerosis, 1973